Haemonetics Corporation(NYSE:HAE) announced the earnings results for Fiscal Year 2017 and Q1. The results came in during Pre-market on Aug 1, 2016. Company reported revenue of $209.96M. Analysts estimated a revenue of $205.24M. Earnings per share were $0.25. Analysts had estimated an EPS of $0.29.
In a different note, On May 16, 2016, Goldman Sachs said it Upgrades its rating on Haemonetics Corporation. In the research note, the firm Raises the price-target to $25.00 per share. The shares have been rated ‘Neutral’ by the firm.
Haemonetics Corporation (HAE) shares turned negative on Mondays trading session with the shares closing down -0.06 points or -0.17% at a volume of 3,55,736. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $35.67. The peak price level was also seen at $35.67 while the days lowest was $35.09. Finally the shares closed at $35.35. The 52-week high of the shares is $40.14 while the 52-week low is $25.98. According to the latest information available, the market cap of the company is $1,813 M.
Several Insider Transactions has been reported to the SEC. On Oct 28, 2015, Sandra Jesse (EVP and Chief Legal Officer) sold 778 shares at $32.13 per share price.Also, On Oct 28, 2015, Byron Selman (President, Global Markets) sold 344 shares at $32.13 per share price.On Oct 28, 2015, Jonathan White (Chief Science and Technology) sold 319 shares at $32.13 per share price, according to the Form-4 filing with the securities and exchange commission.
Haemonetics Corporation is a healthcare company which provides blood management solutions to its customers. The Company’s portfolio of integrated devices information management and consulting services offers blood management solutions for each facet of the blood supply chain. It serves three customer segments: manufacturers of plasma derived pharmaceuticals blood collectors and hospitals. Its multiple product lines under four global product categories include Plasma Blood Center Hospital and Software Solutions. Its Plasma includes plasma collection devices and disposables. Its Blood Center includes blood collection and processing devices and disposables. Its Hospital includes surgical blood salvage and blood demand diagnostic devices and disposables. Its Software Solutions includes information technology platforms and consulting services provided to all three markets. It operates in North America Plasma North America Blood Center and Hospital Europe Asia Pacific and Japan.